Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI
Article in Frontiers in Pharmacology (February 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (February 2024)
Article in Reactions Weekly (February 2024)